by The global Pulse Electromagnetic Field Therapy Devices market size is expected to be worth around US$ 705.3 million by 2030, according to a new report by Vision Research Reports.
The global Pulse Electromagnetic Field Therapy Devices market size was valued at US$ 401.5 million in 2020 and is anticipated to grow at a CAGR of 8.8% during forecast period 2021 to 2030.
Download Exclusive Sample of Report@ https://www.visionresearchreports.com/report/sample/38985
Table of Contents
Pulse Electromagnetic Field Therapy Devices Market Growth Factors
Increasing focus on the development of advanced products is expected to boost the market growth. Furthermore, increasing cases of sports injuries and road accidents are expected to boost the demand for these devices, thereby augmenting the market growth. For instance, according to the WHO, about 1.3 million people die every year due to road traffic crashes.
The increasing geriatric population across the globe and rising awareness regarding pulse electromagnetic field (PEMF) therapy devices are anticipated to boost the market growth. Technological advancements, such as the development of narrow, miniaturized PEMF therapy devices using advanced materials are expected to secure the market position. The integration of telemedicine is expected to expand the application scope of these devices.
Pulse Electromagnetic Field Therapy Devices Market Report Coverage
| Report Scope | Details |
| Market Size | US$ 705.3 million by 2030 |
| Growth Rate | CAGR of 8.8% From 2021 to 2030 |
| Base Year | 2021 |
| Forecast Period | 2021 to 2030 |
| Segments Covered | Power, Application, End-use |
| Regional Scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Companies Mentioned | Bedfont Scientific; Orthofix Holdings; I_Tech Medical Division; OSKA; Medithera; NiuDesai; Nuage Health; Oxford Medical Instruments Health; Bemer, LLC |
By Power Analysis
Based on power, the PEMF therapy devices market is segmented into low frequency and high frequency. The low-frequency power segment accounted for the largest revenue share of more than 62% in 2020.
The high-frequency power segment is expected to grow at the fastest CAGR during the forecast period. High-frequency PEMF devices are suited for the treatment of conditions affecting soft tissues including muscles and tendons. Researchers have found that these devices improved edema up to some hours after the treatment session.
By Application Analysis
The pain relief application segment accounted for the highest revenue share of more than 44.5% in 2020. PEMF therapy devices provide an optimal magnetic field that reduces pain by enhancing the expansion and contraction of cells and also by detoxifying and regenerating damaged cells.
The bone growth segment is estimated to register a significant CAGR from 2021 to 2030. Pulsed electromagnetic fields are known to act on bone and osteoblasts, affecting its metabolism, despite the poor understanding of underlying mechanisms.
By End-use Analysis
The hospitals segment led the market in 2020 and accounted for more than 50% of the global revenue share. Hospitals are majorly the first choice of patients to visit for chronic pain and several bone disorders including osteoporosis and osteoarthritis, among others.
The home care settings segment is expected to grow at a significant CAGR from 2021 to 2030. The growth can be attributed to the rising healthcare awareness among individuals and product advancements.
By Regional Analysis
North America dominated the market and accounted for the largest revenue share of 42.2% in 2020. An increasing number of patients suffering from osteoporosis and osteoarthritis is predicted to boost the demand for PEMF therapy devices in the U.S. and Canada.
In Asia Pacific, the market is estimated to witness the fastest CAGR during the forecast period. Rising patient awareness levels related to the commercial availability of PEMF therapy devices and constantly improving healthcare infrastructure are anticipated to accelerate the market growth.
Read also @ Drainage Bottles Market Insight and Trends 2030
Major Key Players Covered in The Pulse Electromagnetic Field Therapy Devices Market Report include
- Bedfont Scientific
- Orthofix Holdings
- I-Tech Medical Division
- OSKA
- Medithera
- NiuDeSai
- Nuage Health
- Oxford Medical Instruments Health
- Bemer, LLC
Pulse Electromagnetic Field Therapy Devices Market Segmentation
- By Power
- Low Frequency
- High Frequency
- By Application
- Pain Management
- Bone Growth
- Others
- By End-use
- Hospitals
- Home Care Settings
- Others
- Regional
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Italy
- Spain
- Asia Pacific
- China
- Japan
- India
- Thailand
- Australia
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Middle East and Africa
- Saudi Arabia
- South Africa
- UAE
- North America
Table of Contents
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Pulse Electromagnetic Field Therapy Devices Market Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Pulse Electromagnetic Field Therapy Devices Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Pulse Electromagnetic Field Therapy Devices Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Pulse Electromagnetic Field Therapy Devices Market, By Power
7.1. Pulse Electromagnetic Field Therapy Devices Market, by Power, 2021-2030
7.1.1. Low Frequency
7.1.1.1. Market Revenue and Forecast (2017-2030)
7.1.2. High Frequency
7.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 8. Global Pulse Electromagnetic Field Therapy Devices Market, By Application
8.1. Pulse Electromagnetic Field Therapy Devices Market, by Application, 2021-2030
8.1.1. Pain Management
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Bone Growth
8.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Pulse Electromagnetic Field Therapy Devices Market, By End User
9.1. Pulse Electromagnetic Field Therapy Devices Market, by End User, 2021-2030
9.1.1. Hospitals
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Home Care Settings
9.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Pulse Electromagnetic Field Therapy Devices Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Power (2017-2030)
10.1.2. Market Revenue and Forecast, by Application (2017-2030)
10.1.3. Market Revenue and Forecast, by End User (2017-2030)
10.1.4. U.S.
10.1.4.1. Market Revenue and Forecast, by Power (2017-2030)
10.1.4.2. Market Revenue and Forecast, by Application (2017-2030)
10.1.4.3. Market Revenue and Forecast, by End User (2017-2030)
10.1.5. Rest of North America
10.1.5.1. Market Revenue and Forecast, by Power (2017-2030)
10.1.5.2. Market Revenue and Forecast, by Application (2017-2030)
10.1.5.3. Market Revenue and Forecast, by End User (2017-2030)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Power (2017-2030)
10.2.2. Market Revenue and Forecast, by Application (2017-2030)
10.2.3. Market Revenue and Forecast, by End User (2017-2030)
10.2.4. UK
10.2.4.1. Market Revenue and Forecast, by Power (2017-2030)
10.2.4.2. Market Revenue and Forecast, by Application (2017-2030)
10.2.4.3. Market Revenue and Forecast, by End User (2017-2030)
10.2.5. Germany
10.2.5.1. Market Revenue and Forecast, by Power (2017-2030)
10.2.5.2. Market Revenue and Forecast, by Application (2017-2030)
10.2.5.3. Market Revenue and Forecast, by End User (2017-2030)
10.2.6. France
10.2.6.1. Market Revenue and Forecast, by Power (2017-2030)
10.2.6.2. Market Revenue and Forecast, by Application (2017-2030)
10.2.6.3. Market Revenue and Forecast, by End User (2017-2030)
10.2.7. Rest of Europe
10.2.7.1. Market Revenue and Forecast, by Power (2017-2030)
10.2.7.2. Market Revenue and Forecast, by Application (2017-2030)
10.2.7.3. Market Revenue and Forecast, by End User (2017-2030)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Power (2017-2030)
10.3.2. Market Revenue and Forecast, by Application (2017-2030)
10.3.3. Market Revenue and Forecast, by End User (2017-2030)
10.3.4. India
10.3.4.1. Market Revenue and Forecast, by Power (2017-2030)
10.3.4.2. Market Revenue and Forecast, by Application (2017-2030)
10.3.4.3. Market Revenue and Forecast, by End User (2017-2030)
10.3.5. China
10.3.5.1. Market Revenue and Forecast, by Power (2017-2030)
10.3.5.2. Market Revenue and Forecast, by Application (2017-2030)
10.3.5.3. Market Revenue and Forecast, by End User (2017-2030)
10.3.6. Japan
10.3.6.1. Market Revenue and Forecast, by Power (2017-2030)
10.3.6.2. Market Revenue and Forecast, by Application (2017-2030)
10.3.6.3. Market Revenue and Forecast, by End User (2017-2030)
10.3.7. Rest of APAC
10.3.7.1. Market Revenue and Forecast, by Power (2017-2030)
10.3.7.2. Market Revenue and Forecast, by Application (2017-2030)
10.3.7.3. Market Revenue and Forecast, by End User (2017-2030)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Power (2017-2030)
10.4.2. Market Revenue and Forecast, by Application (2017-2030)
10.4.3. Market Revenue and Forecast, by End User (2017-2030)
10.4.4. GCC
10.4.4.1. Market Revenue and Forecast, by Power (2017-2030)
10.4.4.2. Market Revenue and Forecast, by Application (2017-2030)
10.4.4.3. Market Revenue and Forecast, by End User (2017-2030)
10.4.5. North Africa
10.4.5.1. Market Revenue and Forecast, by Power (2017-2030)
10.4.5.2. Market Revenue and Forecast, by Application (2017-2030)
10.4.5.3. Market Revenue and Forecast, by End User (2017-2030)
10.4.6. South Africa
10.4.6.1. Market Revenue and Forecast, by Power (2017-2030)
10.4.6.2. Market Revenue and Forecast, by Application (2017-2030)
10.4.6.3. Market Revenue and Forecast, by End User (2017-2030)
10.4.7. Rest of MEA
10.4.7.1. Market Revenue and Forecast, by Power (2017-2030)
10.4.7.2. Market Revenue and Forecast, by Application (2017-2030)
10.4.7.3. Market Revenue and Forecast, by End User (2017-2030)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Power (2017-2030)
10.5.2. Market Revenue and Forecast, by Application (2017-2030)
10.5.3. Market Revenue and Forecast, by End User (2017-2030)
10.5.4. Brazil
10.5.4.1. Market Revenue and Forecast, by Power (2017-2030)
10.5.4.2. Market Revenue and Forecast, by Application (2017-2030)
10.5.4.3. Market Revenue and Forecast, by End User (2017-2030)
10.5.5. Rest of LATAM
10.5.5.1. Market Revenue and Forecast, by Power (2017-2030)
10.5.5.2. Market Revenue and Forecast, by Application (2017-2030)
10.5.5.3. Market Revenue and Forecast, by End User (2017-2030)
Chapter 11. Company Profiles
11.1. Bedfont Scientific
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Orthofix Holdings
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. I-Tech Medical Division
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. OSKA
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Medithera
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. NiuDeSai
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Nuage Health
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Oxford Medical Instruments Health
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Bemer, LLC
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms
Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/38985
Contact Us:
Vision Research Reports
Call: +1 9197 992 333
